Recent Articles from GlobeNewswire

Company Calls for Consideration of New Regulatory Pathways and Cost Saving of Non-Hallucinogenic Neuroplastogens for Alcohol Use Disorder

Highlights Include Landmark Agreement with Nebius, Expansion of Power Portfolio, and Funding Strategy for CLT1

New dedicated website will showcase the evolution of Fusemachines’ AI Twin technology while inviting discussion on the technical, legal, social, and human implications of AI that can represent people at work

The guest appreciation celebration follows Dave’s recently being named Yelp’s No. 1 Most Loved Brand*

NOVATO, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has entered into a definitive agreement to sell a Rare Pediatric Disease Priority Review Voucher (PRV) for $210 million. Ultragenyx received the PRV upon U.S. Food and Drug Administration (FDA) approval of GENGLYCOS™ (pariglasgene brecaparvovec-opnr), also known as DTX401, the first treatment designed to address the underlying cause of glycogen storage disease type Ia (GSDIa).

PLANTATION, Fla., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Alliance Entertainment Holding Corporation (Nasdaq: AENT), a scaled entertainment commerce and collectibles platform serving content owners, brands, retailers and fans across music, movies, gaming, licensed merchandise and collectibles, with proprietary brands, authentication technology and reach across more than 35,000 retail and e-commerce storefronts, today announced its participation in two upcoming investor conferences in New York City during October 2026.

Preclinical package also shows more than 2.5-fold survival extension in advanced PDAC models; Company contrasts a non-RAS, differentiation-based mechanism with the clinical benchmark set by RASONQUE (daraxonrasib)

BOCA RATON, FL, Oct. 07, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the "Company" or "DeFi Dev Corp."), the first U.S. public company with a treasury strategy built to accumulate and compound Solana ("SOL"), today announced that Chief Executive Officer Joseph Onorati and Chief Strategy Officer Dan Kang will present at the 2026 Maxim Growth Summit, taking place October 12–14, 2026, at the Hard Rock Hotel in New York City.

Licence of up to 20 years, payable in shares, as Malaysia commits RM1 billion to digitalizing public healthcare

Paris and New York, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Cyllene Therapeutics SAS (“Cyllene Tx”), a leader in site-specific, non-systemic DNA medicines for the treatment of prevalent chronic neurological disorders, today announced presentation of interim clinical data from the first two dose cohorts of its Phase 1b/2a trial showing that treatment with EG110A resulted in consistent and clinically relevant reductions in urinary incontinence episodes up to 52 weeks in people with spinal cord injury (“SCI”) with neurogenic detrusor overactivity (“NDO”). This debilitating and prevalent bladder disorder is characterized by uncontrolled urinary incontinence. The data, presented at the 56th International Continence Society Annual Meeting in Maastricht, the Netherlands, also showed EG110A to be well tolerated, with no severe drug related side effects or dose-limiting toxicity.

Integrated Technology Supports Faster Transactions and Streamlined Operations Across Sports, Concerts and Global Events

Management to Review Third-Quarter Performance and Provide Updates on Ongoing Initiatives

Agreement with Mediplexus, a subsidiary of Korean CRO C&R Research, establishes a new Asia Pacific distribution channel for OneMedNet’s first-party, direct-from-source multimodal Real World Data

 

Nature Communications publication provides new evidence that Vaccinex’s pepinemab may help reshape the tumor environment to support a coordinated immune attack on cancer, potentially complementing checkpoint inhibitors and other immunotherapies

Fall 2026 release brings pipeline-ready Markdown extraction, higher-level document generation, more consistent editing APIs, and more resilient document capture directly into Apryse SDKs

Expecting 1.2 Million New Covered Lives from Commitments to Date and Anticipated Remaining Decisions 

TEL AVIV, Israel, Oct. 07, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, that CliniQuantum Ltd. (“CliniQuantum”), NeuroThera’s  majority owned subsidiary, reported that its Graphics Processing Unit- accelerated (“GPU”) quantum-simulation platform achieved an approximately 16.8-fold computational acceleration using a single machine with 64 cores (x86_64) and a single NVIDIA T4 Tensor Core GPU compared with the same 64-vCPU machine with only Central Processing Unit (“CPU”) implementation.

Built as an alternative to traditional private equity, where local owners keep their focus on their teams and customers while American Service Partners provides institutional-grade back-end systems and leading AI synergies

Matthew Latino appointed CFO; Michael Bishop to continue as senior advisor

Boat, watersports, RV, golf cart and powersports businesses can now get answers from their BookingCentral data in seconds

As the FDA opens the door to non-animal safety testing, VivoSim's human-relevant models are already helping lower drug costs

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ: EXLS), a global data and AI company, will release financial results for the third quarter ended September 30, 2026, on Tuesday, October 27, 2026, after the market closes. An earnings news release, investor fact sheet and presentation will be published on the company’s investor relations website offering an overview of the financial results.

AVENTURA, Fla., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Safe Pro Group Inc. (Nasdaq: SPAI) (“Safe Pro” or the “Company”), a developer of artificial intelligence (AI)-enabled defense, security, and situational awareness solutions, today announced preliminary, unaudited revenue expectations for the third quarter ended September 30, 2026.

Si829x platform with ProVCD™ technology moves from development to pre-production release for EV traction inverters

Base award supports late-stage development, regulatory approval activities, and initial procurement of Kaléo’s next-generation 2-PAM auto-injector for organophosphate and nerve agent poisoning

PLANO, Texas, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Deep Isolation Nuclear, Inc. (OTCQB: DBHL) (“Deep Isolation” or the “Company”), a leading innovator in nuclear waste disposal technology, today announced that CEO Rod Baltzer and CFO Joe Nelson will present at three upcoming investor conferences, offering investors opportunities to learn more about the Company’s technology, commercialization strategy and progress toward deploying deep borehole disposal for nuclear waste.

Card-linked mobile app turns gas purchases into micro-offsets for $0.23 per gallon

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against UWM Holdings Corporation (“UWM Holdings” or the “Company”) (NYSE: UWMC) on behalf of investors that purchased or otherwise acquired UWM Holdings securities between March 9, 2026 and August 5, 2026 (the “Class Period”).

CARSON CITY, Nev., Oct. 07, 2026 (GLOBE NEWSWIRE) -- American Lithium Minerals Inc. (OTC: AMLM) today announced that Worldwide Diversified Holdings, Inc. (“Worldwide”) has agreed to convert its outstanding note into AMLM common shares. Under the agreed structure, Worldwide will facilitate an initial transfer of one AMLM common share for every ten Worldwide common shares, scheduled to be completed in the fourth quarter, advancing AMLM’s capital-markets strategy.

ANN ARBOR, Mich., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Esperion, a company wholly-owned by ARCHIMED, today announced that it has entered into a settlement agreement with Renata Limited (along with an affiliate). This agreement resolves the patent litigation brought by Esperion against Renata in response to Renata’s Abbreviated New Drug Applications (ANDAs) seeking approval to market generic versions of NEXLETOL and NEXLIZET prior to the expiration of the applicable patents. Pursuant to the agreement, Renata has agreed not to market a generic version of either NEXLETOL or NEXLIZET in the United States prior to April 19, 2040, unless certain limited circumstances customarily included in these types of agreements occur.

DALLAS, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, today announced that it expects to issue financial results for the third quarter of 2026 after market on Wednesday, October 21, 2026. Executive management will host a conference call and webcast to discuss third quarter 2026 operating results on Wednesday, October 21, 2026, at 5:00 p.m. EDT.

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Madison Realty Capital, working with Newbond Holdings, has provided a loan to a joint venture between Schulte Hospitality Group and an institutional investment partner for Hotel Washington, a 326-key luxury independent hotel located at 515 15th Street NW in Washington, D.C. Schulte Hospitality Group, a boutique and lifestyle hotel specialist managing over 250 properties across 40 states and five countries, operates the property directly.

Earnings Release and Conference Call Scheduled for November 4, 2026

ATSN-201 demonstrated structural and functional benefit in Parts A and B, including microperimetry improvements exceeding the level the FDA has defined as supportive of potential approval

- Three-phase, 36-month award aims to extend BrainEx perfusion from 24 hours to up to two weeks, enabling longitudinal studies of human brain biology and therapeutic responses -

Caregivers say they need clearer pain management plans, earlier education, and practical support on non-opioid options before a loved one undergoes surgery

Vancouver, BC, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour”, “SYH” or the “Company”) is pleased to announce the commencement of drilling at the Getty East Uranium Joint Venture (“Getty East” or the “Property”) representing the first phase of drilling in 2026 at this newly established property. The 3,105-hectare Getty East Property, comprising one claim, is a part of the broader Russell Lake project area and joint venture with Denison Mines Corp. (“Denison”) (TSX: DML) (NYSE American: DNN). The Russell Lake Joint Ventures are strategically located in the central portion of the eastern Athabasca Basin of northern Saskatchewan adjacent and proximal to Denison’s flagship Wheeler River project. There is also access to significant regional infrastructure, including an exploration camp, provincial highways, and the provincial power grid.

Health care technology leaders say operational readiness across people, processes, workflows and revenue cycle is as important as technical preparation

Full one-year results from the KYSA-8 registrational trial in stiff person syndrome to be reported, demonstrating sustained clinical benefit and a well-tolerated safety profile with no high-grade CRS or ICANS and no cases of IEC-HS 

Combination of ruvonoflast and semaglutide produced greater reductions in hsCRP versus semaglutide monotherapy

New AI-powered service combines Aptean’s domain experts, industry-specific software, decades of vertical data, and AI ecosystem

BOSTON, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing targeted therapies for neurodegenerative diseases, today announced positive topline results from ARISE, its randomized, double-blind, placebo-controlled Phase 3 trial of once-daily oral solengepras as an adjunctive treatment for people with Parkinson’s disease experiencing motor fluctuations on levodopa and other Parkinson’s medications. Solengepras is a potential first-in-class therapy that targets the striatal indirect pathway through a novel receptor (GPR6) and has no direct impact on dopamine receptors. The ARISE results support its potential to address both motor and non-motor symptoms of Parkinson’s disease.

New solution enables health systems to move infrequently accessed medical images out of premium storage, retire imaging infrastructure, and preserve fast, governed access to historical studies

An analysis of executives at FTSE-listed companies and more than 322,000 UK Biobank participants finds lower leadership attainment among ethnic Chinese men

Expanded Portfolio Addresses Demand for Secure, High-Throughput Communications Across Swarm-Scale Unmanned Operations

WALTHAM, Mass., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT), a global leader in authentication and traceability technologies, today announced the appointment of Jeong H. Kim to its Board of Directors, effective October 29, 2026.

Irvine and Los Angeles, CA, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Aperture AC (NASDAQ: APUR), a special purpose acquisition company (“Aperture”), and Atlantic HPC Group Inc (“Atlantic”), a U.S.-based digital infrastructure company that develops and operates power-intensive bitcoin mining and computing facilities across Oklahoma, Arkansas, Ohio and  following the Valley Oasis acquisition, Tennessee, today announced that the board of directors of Atlantic has appointed Leo Lin as Atlantic’s Chief Executive Officer, effective October 1, 2026. Lin is a seasoned executive with over 20 years of experience in helping companies scale their operations and achieve rapid growth. Lin succeeds Jacqueline Jiang, who has stepped down as Chief Executive Officer and will continue to serve as a member of Atlantic’s board of directors.

Transaction streamlines business and sharpens focus on core betting, gaming, and media priorities

Bold UK-wide campaign puts craft beer back at the centre of culture, celebrating better ingredients, better quality, skilled brewers, beer lovers and the big flavours that make craft worth choosing.

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Taboola.com Ltd. (“Taboola.com” or the “Company”) (NASDAQ: TBLA) on behalf of investors that purchased or otherwise acquired Taboola.com securities between May 6, 2026 and August 4, 2026 (the “Class Period”).

WALTHAM, Mass., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company advancing therapies for patients living with autoimmune and inflammatory diseases, today announced that it will present seven posters at the 10th Joint ACTRIMS-ECTRIMS Meeting (MSToronto2026) taking place October 21-23, 2026, in Toronto, Canada.

WARSAW, Ind., Oct. 07, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) portfolio with a new product launch, the OPSB® Knee 'TractorFIX contracture management orthosis.

Consistent Use of New Approach Methodologies (NAMs) to Potentially Accelerate BiTAC® Oncology Pipeline and Significantly Reduce Animal Testing Needs

LONDON, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Noah, the stablecoin payments infrastructure provider, has closed its seed funding round at $38 million following the raise of an additional $16 million from existing and new investors. The raise follows strong growth that has seen revenues surge by 538% during year-to-date 2026 compared to the same period 2025, with recurring monthly growth of 31%. Noah has also signed over 150 new customers during 2026 including major enterprises such as they transition to stablecoin transfers.

Final close of Funds 4 and 5 Series 2 takes total capital raised to full target of US$1 billion, with a 99% repeat investment rate

LONDON, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Marex Group Limited (‘Marex’ or the ‘Group’; NASDAQ: MRX) today announces that Chair of the Board Robert Pickering has stepped down from the Group Board, having overseen an exceptional period of growth and change during his appointed three-year term.

– Data showed improvements in an objective measure of impaired eye movement associated with Parkinson’s disease, with a correlation between reductions in LRRK2 cerebrospinal fluid (CSF) biomarkers to these changes in oculomotor function and changes in synaptic biomarkers –

CPU ETF targets approximately 10 semiconductor leaders powering advances across computing & AI, automotive and industrial markets

Financing co-led by Nextech Invest and Norwest, with participation from new and existing investors

MONTRÉAL, Oct. 07, 2026 (GLOBE NEWSWIRE) -- OR Royalties Inc. (“OR Royalties” or the “Company”) (OR: TSX & NYSE) is pleased to announce its third quarter 2026 preliminary deliveries, revenues and cash margin, as well as to provide an update on its cash and debt positions as at September 30, 2026. All monetary amounts included in this report are expressed in United States dollars, unless otherwise noted.

Head-to-head comparison shows 94% concordance with tumor-informed ctDNA testing, with the clinical ground-truth in all discordant cases supporting Northstar Response

NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it will report its financial results for the third quarter of 2026 on Monday, November 2, 2026, before the opening of the U.S. financial markets. Axsome management will then host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update.

SEATTLE, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that data from the Company’s [²¹²Pb]VMT-α-NET program have been accepted for presentation at the NANETS 2026 Multidisciplinary NET Medical Symposium taking place November 5 to 7, 2026, in Las Vegas, Nevada.

Q3 revenue was $1.71 million, up 94% year-over-year and 63% sequentially; company reaches break-even on recurring revenue and monthly profitability

Transaction in Own Shares

TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) (FSE: B4IF) (the “Company” or “Goliath”) is pleased to report several assays from its 2026 drill program where drill hole GD-26-483 intersected 9.89 g/t AuEq over 12.00 meters at the Surebet Discovery on its 100% owned Golddigger Property (the “Property”), Golden Triangle, British Columbia. Recent assay results confirm grade continuity across all major mineralized zones at the Surebet Gold Discovery and demonstrate the predictability of the mineralization model as the system was expanded by more than 1 km along the NE–SW trend by 100 meters to the north and west resulting in a total footprint of the Surebet System of 2.01 Km2. 100% of the drill holes completed to date on Surebet have intersected quartz-sulphide mineralization, where 412 drill holes out of 483 (or 85%) contain VG-NE, clearly demonstrating continuity and predictability of the Surebet System as well as the untapped discovery potential remaining on the property. Assays are still pending for 55 holes drilled in 2026.

TAIPEI, Taiwan, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Gogoro Inc. (“Gogoro,” the “Company” or “we”) (Nasdaq: GGR), a global technology leader in battery swapping ecosystems, today announced the appointment of Peter Ming-Tuan Huang, Su-Ming Lin and Jason Yu-Hsien Chang to its Board of Directors, effective October 7, 2026. Following the appointments, Gogoro’s Board of Directors will consist of seven directors.

TAIPEI, Taiwan, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Gogoro Inc. (“Gogoro,” the “Company” or “we”) (Nasdaq: GGR), a global technology leader in battery swapping ecosystems, today announced a second round of new equity investments by entities controlled by Mr. Chung-Yao Yin, a director of the Company (“Mr. Yin”) and certain strategic investors (collectively, the “Investors”). The aggregate amount of the new equity investments is expected to be approximately $61.8 million.

MONTREAL, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Stella-Jones Inc. (TSX:SJ).

New SoloVitals and SoloScribe capabilities bring contactless vitals and ambient documentation directly into clinical workflows

SAN FRANCISCO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Girard Sharp LLP, a national investment, securities, and consumer class action law firm, has filed a securities class action against Blue Owl Technology Finance Corp. (“OTF”). According to the complaint, the class includes former OTF II shareholders who acquired newly issued OTF common stock in exchange for OTF II securities pursuant to the March 24, 2025 stock-for-stock transaction (the “Merger”) by which OTF merged with and acquired OTF II (the “Class”).

Term Sheet Provides Up to 100 Years of Site Tenure at key Strategic U.S Defense Infrastructure Installation and Advances Development of Fully Integrated U.S. Graphite Supply Chain

SAN FRANCISCO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Girard Sharp LLP, a national investment, securities, and consumer class action law firm, has filed a securities class action against Rocket Companies, Inc. ("Rocket"). According to the complaint, the class includes former Mr. Cooper Group (“Mr. Cooper”) shareholders who acquired newly issued Rocket common stock in exchange for Mr. Cooper securities pursuant to the October 1, 2025 stock-for-stock transaction (the “Merger”) by which Rocket merged with and acquired Mr. Cooper (the “Class”).

TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Northland Power Inc. ("Northland" or the "Company") (TSX: NPI) today announced the completion of turbine installation at Baltic Power, the 1.1 GW offshore wind project in Poland jointly owned by Northland and ORLEN. All 76 turbines are now installed, with over one-third currently generating power. The project is advancing through commissioning and is on track for commercial operations in 2026, with costs aligned with original expectations. Baltic Power achieved first power in July 2026, delivering the first electricity ever generated from offshore wind to Poland’s national grid.